BRAF Inhibitors May Accelerate Wound Healing

Share this content:
BRAF Inhibitors May Accelerate Wound Healing
BRAF Inhibitors May Accelerate Wound Healing

WEDNESDAY, Aug. 3, 2016 (HealthDay News) -- Topical application of BRAF inhibitors may accelerate healing of skin wounds, according to a study published online Aug. 1 in Nature Communications.

Helena Escuin-Ordinas, Ph.D., from the University of California in Los Angeles, and colleagues examined how the BRAF inhibitor vemurafenib accelerates skin wound healing in two wound-healing mice models.

The researchers found that topical treatment with vemurafenib accelerated wound healing through paradoxical mitogen-activated protein kinase activation; the benefit of vemurafenib-accelerated wound healing was reversed by additional of a MEK inhibitor. The same dosing regimen of topical BRAF inhibitor did not increase cutaneous squamous cell carcinoma incidence in mice.

"Topical BRAF inhibitors may have clinical applications in accelerating the healing of skin wounds," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Improved clinical global impression and change in visual analog scale, pain at 4 to 8 weeks post therapy

Professionals Disagree About Asking Patients About Sexuality

Professionals Disagree About Asking Patients About Sexuality

Article offers opposing views about recommendation in England to ask patients about sexual orientation

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Greater improvement in symptom scores versus placebo, but clinical relevance unclear

is free, fast, and customized just for you!

Already a member?

Sign In Now »